The economics of stratified medicine

• In: D8 - How patient stratification and pharmacogenetics affect ADRs in complex patients on Thursday, 5 September 2013, 14:00-17:00
• At: Dublin (Ireland) (2013)
• Type: Presentation
• By: REDEKOP, Ken (Erasmus University, Institute for Medical Technology Assessment, Rotterdam, Netherlands)
• Abstract:

  
  Background
  : Stratified medicine (SM) refers to the separation of a patient population into more homogeneous subgroups, with the overall aim of distinguishing between the patients likely to benefit from a treatment and the patients unlikely to benefit. SM can thereby increase the average treatment effectiveness (by filtering out non-responders) and

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login